0001640334-17-001019.txt : 20170518 0001640334-17-001019.hdr.sgml : 20170518 20170518121510 ACCESSION NUMBER: 0001640334-17-001019 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170512 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year FILED AS OF DATE: 20170518 DATE AS OF CHANGE: 20170518 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GREEN VISION BIOTECHNOLOGY CORP. CENTRAL INDEX KEY: 0001571804 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 981060941 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-55210 FILM NUMBER: 17854164 BUSINESS ADDRESS: STREET 1: 1255 W. RIO SALADO PARKWAY STREET 2: SUITE 215 CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 7029972267 MAIL ADDRESS: STREET 1: 1255 W. RIO SALADO PARKWAY STREET 2: SUITE 215 CITY: TEMPE STATE: AZ ZIP: 85281 FORMER COMPANY: FORMER CONFORMED NAME: VIBE WIRELESS CORP. DATE OF NAME CHANGE: 20151116 FORMER COMPANY: FORMER CONFORMED NAME: ANYTRANSLATION CORP DATE OF NAME CHANGE: 20130312 8-K/A 1 vibx_8ka.htm FORM 8-K/A vibx_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

Amendment No. 1

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

May 12, 2017

Date of Report (Date of earliest event reported)

 

GREEN VISION BIOTECHNOLOGY CORP.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-55210

 

98-1060941

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

1255 W. Rio Salado Parkway

Suite 215

Tempe, AZ 85281

 

85281

(Address of principal executive offices)

 

(Zip Code)

 

(480) 339-0181

Registrant’s telephone number, including area code

 

______________________________________________

 (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 
 

Explanatory Note

 

This Amendment No. 1 on Form 8-K/A (this “Form 8-K/A”) is an amendment to the Current Report on Form 8-K of Green Vision Biotechnology Corp. (“GVBT”), dated May 12, 2017 (the “Original Form 8-K”). This Form 8-K/A is being filed solely to amend and restate Item 5.03 of the Original Form 8-K. This Form 8-K/A amends and restates in its entirety Item 5.03 of the Original Form 8-K and should be read in connection with the Original Form 8-K. No other changes were made to the Original Form 8-K.

  

5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR

 

The fiscal year-end for Lutu International is December 31. On May 12, 2017, the board of directors of GVBT approved changing the fiscal year-end of GVBT from January 31 to December 31, to be effective immediately as of May 12, 2017. Under the applicable rules of the Securities and Exchange Commission, GVBT intends to file a transition report on Form 10-QT for the quarter ended June 30, 2017.

 

 
2
 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

GREEN VISION BIOTECHNOLOGY CORP. 

 

 

DATE: May 18, 2017

 

     
By: /s/ Lam Ching Wan

Name:

Lam Ching Wan  
Title: Chief Executive Officer  

 

 

3